http://blog.pharmexec.com/2008/10/06/lilly-puts-up-65-billion-for-imclone/ The Business of Pharmaceuticals Wed, 10 Mar 2010 16:21:20 -0500 hourly 1 http://blog.pharmexec.com/2008/10/06/lilly-puts-up-65-billion-for-imclone/comment-page-1/#comment-15988 Annette Kreuger VP Pharmaceutical-Biotech Group Tue, 07 Oct 2008 13:43:09 +0000 http://blog.pharmexec.com/?p=272#comment-15988 Despite being an "old-guard" pharma company, Eli Lilly is showing the capacity to change with the times. While selling off a number of plants to Covance and then sliding under the radar to snap up Imclone from under BMS, the company is positioning itself not only to survive, but to suceed. Despite being an “old-guard” pharma company, Eli Lilly is showing the capacity to change with the times. While selling off a number of plants to Covance and then sliding under the radar to snap up Imclone from under BMS, the company is positioning itself not only to survive, but to suceed.

]]>